In the SURPASS-2 trial, which directly compared tirzepatide to semaglutide 1 mg for type 2 diabetes, nausea rates were 17-22% for tirzepatide across all three dose levels (5 mg, 10 mg, and 15 mg) versus 18% for semaglutide 1 mg
Challenges in transitioning between medications The transition from semaglutide to tirzepatide may not be as simple as stopping the other medication in favor of starting the other
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
The best way to prevent that is by building muscle
Whether you want to lose weight, manage diabetes, or feel your best, weve got you covered
People who want to try semaglutide with B12 should compare it to these other treatments based on their health goals, how they want to take medicine, and which side effects they want to avoid